Clinic
Amd Urgent Medical Care, PLLC
Amd Urgent Medical Care, PLLC was paid $5.50M by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoAMD URGENT MEDICAL CARE, PLLC
CLIO, MI 48420
CLIO, MI 48420
33aNPI1184968679assigned 11/21/2012
33bProvider typeUrgent Care Clinic/Center
28Total paid$5.50M
24GClaims130,254
24DCodes billed44
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#10 of 239
Median peer was paid$346K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,948 | $793K | |
| 2019 | 22,102 | $738K | |
| 2020 | 17,715 | $569K | |
| 2021 | 21,741 | $1.10M | |
| 2022 | 21,431 | $1.02M | |
| 2023 | 16,508 | $744K | |
| 2024incomplete | 8,809 | $531K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 37,896 | 34,923 | $2.34M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 25% | 14,753 | 13,959 | $1.37M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.8% | 4,675 | 4,651 | $426K |
| 99205 | Prolong outpt/office vis | 7.7% | 3,537 | 3,503 | $423K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.6% | 6,429 | 6,038 | $198K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.3% | 1,666 | 1,614 | $181K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 7,955 | 7,788 | $103K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 6,169 | 3,778 | $98K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 8,687 | 7,436 | $73K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 3,438 | 3,295 | $58K |
| 81025 | <1% | 5,599 | 5,399 | $37K | |
| 74018 | <1% | 1,154 | 1,128 | $18K |
32 more codes
| 73610 | <1% | 923 | $17K | |
| 73130 | <1% | 870 | $16K | |
| 73630 | <1% | 905 | $16K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,806 | $14K |
| 81003 | <1% | 7,244 | $13K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,119 | $12K |
| 87428 | <1% | 376 | $10K | |
| 86769 | <1% | 259 | $9K | |
| 73110 | <1% | 319 | $7K | |
| 80053 | Comprehensive metabolic panel | <1% | 758 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 442 | $6K |
| 99000 | <1% | 895 | $6K | |
| 93000 | <1% | 716 | $6K | |
| 73562 | <1% | 271 | $5K | |
| 29515 | <1% | 131 | $5K | |
| 12001 | <1% | 99 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,996 | $4K |
| 87807 | <1% | 378 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 654 | $4K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,114 | $2K |
| 90714 | <1% | 71 | $2K | |
| 72100 | <1% | 64 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 963 | $941.19 |
| 10060 | <1% | 13 | $917.99 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 102 | $538.58 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 71 | $512.01 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 601 | $462.48 |
| 73030 | <1% | 26 | $449.11 | |
| 74022 | <1% | 14 | $337.52 | |
| 73080 | <1% | 12 | $199.68 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 871 | $1.81 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 213 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMASSIMINO, PAUL (OPERATION MANAGER)
| Provider | Location | Paid |
|---|---|---|
| PPSMG Urgent Medical Care, PLLC | Swartz Creek, MI | $3.24M |
| MD Enterprises PLLC | Davison, MI | $2.63M |
| Amd Primary Care, PLLC | Swartz Creek, MI | $969K |
| Amd Urgent Care Fenton | Fenton, MI | $235K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.